GlaxoSmithKline
GSK
#291
Rank
$68.43 B
Marketcap
$33.24
Share price
-2.22%
Change (1 day)
-3.58%
Change (1 year)

GlaxoSmithKline (GSK) - Cash on Hand

Cash on Hand as of September 2024 : $4.29 Billion USD

According to GlaxoSmithKline's latest financial reports the company has $4.29 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

GlaxoSmithKline - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$6.35 B-31.52%
2022-12-31$9.28 B66.4%
2021-12-31$5.58 B-33.63%
2020-12-31$8.41 B39.85%
2019-12-31$6.01 B19.7%
2018-12-31$5.02 B-4.95%
2017-12-31$5.28 B-14.08%
2016-12-31$6.15 B-29.69%
2015-12-31$8.75 B27.54%
2014-12-31$6.86 B-25.72%
2013-12-31$9.23 B34%
2012-12-31$6.89 B-24.8%
2011-12-31$9.16 B-4.85%
2010-12-31$9.63 B-14.24%
2009-12-31$11.23 B11.57%
2008-12-31$10.06 B11.72%
2007-12-31$9.01 B51.41%
2006-12-31$5.95 B-34.03%
2005-12-31$9.02 B18.17%
2004-12-31$7.63 B23.7%
2003-12-31$6.17 B55.92%
2002-12-31$3.95 B17.62%
2001-12-31$3.36 B-37.22%
2000-12-31$5.36 B68.76%
1999-12-31$3.17 B1.35%
1998-12-31$3.13 B14.81%
1997-12-31$2.73 B26.34%
1996-12-31$2.16 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$7.07 B 64.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.95 B 131.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.59 B 239.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.02 B 226.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$7.28 B 69.45%๐Ÿ‡ซ๐Ÿ‡ท France
$3.31 B-22.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$0.73 B-82.89%๐Ÿ‡บ๐Ÿ‡ธ USA